Dionysios V. Chartoumpekis, Chun-Yan Fu, Panos G. Ziros, & Gerasimos P. Sykiotis. (2020). Patent Review (2017-2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases. MDPI AG.
Chicago Style (17th ed.) CitationDionysios V. Chartoumpekis, Chun-Yan Fu, Panos G. Ziros, and Gerasimos P. Sykiotis. Patent Review (2017-2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases. MDPI AG, 2020.
MLA (9th ed.) CitationDionysios V. Chartoumpekis, et al. Patent Review (2017-2020) of the Keap1/Nrf2 Pathway Using PatSeer Pro: Focus on Autoimmune Diseases. MDPI AG, 2020.
Warning: These citations may not always be 100% accurate.